In 2024, products for testing for hereditary cancers accounted for the largest revenue of U.S. American company Myriad Genetics. In the latest year, products for hereditary cancer generated a revenue of over *** million U.S. dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
U.S. Securities and Exchange Commission. (May 2, 2025). Revenue of Myriad Genetics from 2022 to 2024, by product type (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/1622945/myriad-genetics-revenue-by-product-type/
U.S. Securities and Exchange Commission. "Revenue of Myriad Genetics from 2022 to 2024, by product type (in million U.S. dollars)." Chart. May 2, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/1622945/myriad-genetics-revenue-by-product-type/
U.S. Securities and Exchange Commission. (2025). Revenue of Myriad Genetics from 2022 to 2024, by product type (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/1622945/myriad-genetics-revenue-by-product-type/
U.S. Securities and Exchange Commission. "Revenue of Myriad Genetics from 2022 to 2024, by Product Type (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 2 May 2025, /statistics/1622945/myriad-genetics-revenue-by-product-type/
U.S. Securities and Exchange Commission, Revenue of Myriad Genetics from 2022 to 2024, by product type (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1622945/myriad-genetics-revenue-by-product-type/ (last visited July 26, 2026)
Revenue of Myriad Genetics from 2022 to 2024, by product type (in million U.S. dollars) [Graph], U.S. Securities and Exchange Commission, May 2, 2025. [Online]. Available: /statistics/1622945/myriad-genetics-revenue-by-product-type/
